Video
ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Myeloma highlights from ASH 2019
Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA
Weekly wKRd-D in newly diagnosed multiple myeloma achieves unprecedented results
Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA
Chronic lymphocytic leukaemia highlights from ASH 2019
Dr John Seymour - Peter MacCallum Cancer Centre, Melbourne, Australia
Benefits of apixaban among venous thromboembolism patients with active cancer
Dr Alexander Cohen - Guys and St Thomas, London, UK
Inotuzumab ozogamicin and chemotherapy with or without blinatumomab in Philadelp...
Dr Nicholas Short - MD Anderson Cancer Center, Houston, USA
Updates on REGN1979 in R/R B-cell non-Hodgkins lymphoma
Dr Rajat Bannerji - Rutgers Cancer Institute of New Jersey, New Brunswick, USA
Eligibility criteria in acute myeloid leukaemia clinical trials
Dr Mikkael Sekeres - Cleveland Clinic, Cleveland, USA
Azacitidine plus nivolumab in older adults with AML or MDS
Prof Annette Hay - Queen's University, Ontario, Canada
Precision medicine treatment in older AML: Results of Beat AML master trial
Dr Amy Burd - Leukemia and Lymphoma Society, White Plains, USA
Older patients with non-Hodgkin lymphoma can be treated successfully with CAR T-...
Dr Karl Kilgore - Avalere Health, Bowie, USA
Blinatumomab vs chemotherapy as post-reinduction therapy in HR/IR first relapse ...
Dr Patrick Brown - Johns Hopkins University, Baltimore, USA
CANDOR: Triple drug combo delays disease progression in stubborn multiple myelom...
Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA